Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1985 Dec;30(6):514-38.
doi: 10.2165/00003495-198530060-00004.

Suprofen. A review of its pharmacodynamic and pharmacokinetic properties, and analgesic efficacy

Review

Suprofen. A review of its pharmacodynamic and pharmacokinetic properties, and analgesic efficacy

P A Todd et al. Drugs. 1985 Dec.

Abstract

Suprofen (sutoprofen) is a non-steroidal anti-inflammatory analgesic, closely related structurally to drugs such as ibuprofen, ketoprofen and naproxen. In patients with acute pain, single oral doses of suprofen are at least as effective as: usual therapeutic doses of aspirin; codeine alone or combined with aspirin; dextropropoxyphene alone or in various combinations; oxycodone combined with aspirin; dipyrone; pentazocine; paracetamol (acetaminophen); diflunisal; ibuprofen; indomethacin; or mefenamic acid. In chronic pain due to osteoarthritis, suprofen is as effective as usual dosages of aspirin or dextropropoxyphene during long term therapy, and as effective as diclofenac, ibuprofen, indomethacin and naproxen during short term treatment. As with other non-steroidal anti-inflammatory drugs, gastrointestinal complaints are the most frequently reported side effects, although discontinuation due to gastrointestinal effects may be necessary less frequently with suprofen than with aspirin, dextropropoxyphene or combinations of the two. Suprofen appears to be a useful alternative to mild analgesics, analgesic combinations or the older more established non-steroidal anti-inflammatory drugs in the treatment of patients with acute or chronic pain. However, further definition of its efficacy and tolerability is required, especially in comparison with newer non-steroidal anti-inflammatory analgesics.

PubMed Disclaimer

Similar articles

References

    1. Thromb Res. 1976 Feb;8(2):179-93 - PubMed
    1. Kansenshogaku Zasshi. 1983 Jan;57(1):62-81 - PubMed
    1. Arch Int Pharmacodyn Ther. 1977 Apr;226(2):341-3 - PubMed
    1. Arzneimittelforschung. 1985;35(4):745-8 - PubMed
    1. Eur J Rheumatol Inflamm. 1983;6(2):216-21 - PubMed

MeSH terms

LinkOut - more resources